CAMH scientists have identified an interaction between dopamine transporter DAT and the presynaptic dopamine type 2 receptor (D2) which is thought to be an underlying cause for Attention Deficit Hyperactivity Disorder (ADHD). By characterizing this interaction, our scientists have developed a peptid.....
[更多]
Project ID: D2016-29 IP Status: PCT patent application filed Invention Description and Novelty: “Thin” molecules offer stronger binding to PPAR and include greater lipid burning and glucose lowering properties. Applications: Dyslipidemia, obesity and type II diabetes Value propositions: • B.....
[更多]
| |<首頁 <-上一頁 下一頁-> 末頁>| |
